Tag Archives: Bioprojet

Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts

Two biotechs this week topped the $100 million mark in their respective initial public offerings, both of which were able to offer more shares than planned. One, a company with nearly nine month’s-worth of revenue from a newly commercialized drug and the other, an early-clinical stage oncology drug developer, illustrate the range of biotech companies […]

Posted in National, National blog main, National top stories, Philadelphia Blog Main, Philadelphia Top stories, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , | Comments Off on Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts